Grace Therapeutics Inc. (GRCE) Live Share Price, Invest From India

Grace Therapeutics Inc. Stock Performance

as on June 27, 2026 at 2:16 pm IST

Day's Low
Day's High
$2.32
Day's Price Range
$2.45
$2.38
2.52%
Downside
2.94%
Upside
52 Week's Low
52 Week's High
$1.79
52-Week Price Range
$5.18
$2.38
24.79%
Downside
117.65%
Upside

Grace Therapeutics Inc. share price movements today

Previous Close: $2.37
Open: $2.35
Volume: 2.8M
Day's Low - High: $2.32 - $2.45
52 Week Low - High: $1.79 - $5.18

Grace Therapeutics Inc. Historical Returns

1 Month Return: + 0.42 %
3 Month Return: -50.31 %
1 Year Return: -19.39 %
3 Year Return: 0 %
5 Year Return: 0 %

Grace Therapeutics Inc. Stock Fundamentals & Key Indicators

Check Grace Therapeutics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$37.9M

EPS (TTM)

-1.0265

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

-11.94%

Grace Therapeutics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Grace Therapeutics Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Grace Therapeutics Inc.	NA	$37.9M	NA	NA	0.00%	NA
Alnylam Pharmaceuticals Inc.	BUY	$39.3B	67.15%	74.07	12.55%	NA
Vertex Pharmaceuticals Inc.	BUY	$120.6B	147.08%	28.17	35.51%	NA
Regeneron Pharmaceuticals Inc.	BUY	$65.4B	12.64%	15.22	29.65%	0.58%

Stock Returns calculator for Grace Therapeutics Inc. Stock including INR - Dollar returns

The Grace Therapeutics Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Grace Therapeutics Inc. investment value today

Current value as on today

₹89,076

Returns

-₹10,924

(-10.92%)

Returns from Grace Therapeutics Inc. Stock

-₹19,048 (-19.05%)

Dollar Impact

₹8,124 (+8.12%)

Indian Investors' Interest in Grace Therapeutics Inc. Stock

Search interest for Grace Therapeutics Inc. Stock has decreased by -83% in the last 30 days, reflecting a downward trend in search activity.

Time period: May 30, 2026 to June 29, 2026

Change:-83% versus previous 30 day period

Grace Therapeutics Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	-	-	-	-	-	0	-	-	-	-
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-4	-4	-6	-6	-5	-4	-3	-3	-3	-3
EBITDA	-4	-4	-6	-6	-5	-4	-3	-3	-3	-3
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	-	0	0
Income Before Tax	-3	-5	-4	-5	-6	0	-3	-1	-3	-2
Income Tax Expense	0	-1	0	-1	0	-1	-	-	-	-1
Net Income	-3	-4	-3	-4	-5	0	-3	-1	-3	-1
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	11321.66%	0.00%	0.00%	0.00%	0.00%

Grace Therapeutics Inc. Annual Profit & Loss

All numbers in Millions USD

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Total Revenue	0	-	-	-	-	-
Gross Profit	0	-	0	0	0	0
Operating Income	-25	-19	-70	-17	-23	-11
EBITDA	-15	-19	-24	-15	-23	-11
Interest Expense	0	-	-	-	-	-
Depreciation	0	-	0	0	0	0
Income Before Tax	-31	-13	-70	-19	-18	-9
Income Tax Expense	-	0	-12	-2	-4	-1
Net Income	-31	-12	-57	-17	-13	-7
Net Profit Margin	-10039.81%	0.00%	0.00%	0.00%	0.00%	0.00%

Grace Therapeutics Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-3	-2	-3	-4	0	-3	0	-2	-1
Operating Cash Flow	-2	-3	-4	-4	-2	-1	-3	-2	-1
Investing Cash Flow	6	0	0	0	-	-	-	-	-
Financing Cash Flow	0	-	-	-	14	0	0	4	0
Change in Cash	4	-3	-4	-4	11	-2	-3	1	-1

Grace Therapeutics Inc. Annual Cash Flow

All numbers in Millions USD

	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Net Income	-16	-39	-36	-24	-9	-42	-12	-9	-7
Operating Cash Flow	-9	-24	-32	-17	-17	-15	-12	-14	-8
Investing Cash Flow	0	-9	11	-12	-3	13	0	-	-
Financing Cash Flow	8	45	18	74	-	0	7	14	3
Change in Cash	-1	10	-3	46	-20	-2	-4	0	-5

Global Institutional Holdings in Grace Therapeutics Inc.

Funds	Holdings
Diametric Capital, LP	0.26%
UBS Group AG	0.17%
Bank of America Corp	3.2%
Citadel Advisors Llc	0.64%
HPM Partners LLC	5.49%

See all

Insights on Grace Therapeutics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Regeneron Pharmaceuticals, Inc. Common Stock has given 21.5% return, outperforming this stock by 41.4%
NO EFFECT
Against Peers
In the last 3 years, Grace Therapeutics, Inc. Common Stock has experienced a drawdown of -24.4%, however Alnylam Pharmaceuticals, Inc. Common Stock resisted the overall trend and outperformed by 14.8%
NEGATIVE IMPACT
Price Dip
In the last 3 months, GRCE stock has moved down by -49.0%

About Grace Therapeutics Inc.

Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. The company's lead product candidate is the GTX-104, an injectable formulation developed to treat aneurysmal subarachnoid hemorrhage. It also develops GTX-102, an oral mucosal spray of betamethasone to enhance neurological symptoms of Ataxia-Telangiectasia (A-T); and GTX-101, a topical bio adhesive film-forming bupivacaine spray for the treatment of pain associated with postherpetic neuralgia (PHN). The company was formerly known as Acasti Pharma Inc. and changed its name to Grace Therapeutics, Inc. in October 2024. Grace Therapeutics, Inc. was incorporated in 2002 and is headquartered in Princeton, New Jersey.

Organisation	Grace Therapeutics Inc.
Headquarters	103 Carnegie Center, Princeton, NJ, United States, 08540
Industry	Biotechnology
CEO	Mr. Prashant Kohli
E-voting on shares	Click here to vote

Key Management of Grace Therapeutics Inc.

Name	Title
Ms. Carrie D'Andrea	VP of Clinical Operations
Mr. Robert J. DelAversano CPA	VP of Finance and Principal Financial & Accounting Officer
Dr. R. Loch MacDonald M.D., Ph.D.	Member of Scientific Advisory Board & Chief Medical Officer
Mr. Prashant Kohli	CEO & Director
Mr. Amresh Kumar Ph.D.	VP of Program Management

FAQs

What is Grace Therapeutics Inc. share price today?

Grace Therapeutics Inc. share price today is $2.38 as on June 27, 2026 at 8:46 am IST at the close of the market. Grace Therapeutics Inc. share today touched a day high of $2.45 and a low of $2.32.

What is the 52 week high and 52 week low for Grace Therapeutics Inc. share?

Grace Therapeutics Inc. share touched a 52 week high of $5.18 on April 2, 2026 and a 52 week low of $1.79 on April 23, 2026. Grace Therapeutics Inc. stock price today i.e. June 27, 2026 at 8:46 am IST is closed at $2.38,which is 54.05% down from its 52 week high and 32.96% up from its 52 week low.

What is Grace Therapeutics Inc.'s market capitalisation today?

Grace Therapeutics Inc. market capitalisation is $0.00T as on June 27, 2026 at 8:46 am IST.

How to invest in Grace Therapeutics Inc. Stock (GRCE) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Grace Therapeutics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Grace Therapeutics Inc. Shares that will get you 0.6303 shares as per Grace Therapeutics Inc. share price of $2.38 per share as on June 27, 2026 at 8:46 am IST.

What is the minimum amount required to buy Grace Therapeutics Inc. Stock (GRCE) from India?

Indian investors can start investing in Grace Therapeutics Inc. (GRCE) shares with as little as ₹94.3 or $1 (as of June 29, 2026 at 3:02 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹943.00 in Grace Therapeutics Inc. stock (as per the Rupee-Dollar exchange rate as on June 29, 2026 at 3:02 am IST). Based on Grace Therapeutics Inc. share’s latest price of $2.38 as on June 27, 2026 at 8:46 am IST, you will get 4.2017 shares of Grace Therapeutics Inc.. Learn more about fractional shares .